美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
82983-402-10	82983-402	HUMAN PRESCRIPTION DRUG	Tacrolimus	Tacrolimus	CAPSULE	ORAL	20230131	N/A	ANDA	ANDA206651	Ajenat Pharmaceuticals LLC	TACROLIMUS	5 mg/1	100 CAPSULE in 1 BOTTLE (82983-402-10)
82983-401-10	82983-401	HUMAN PRESCRIPTION DRUG	Tacrolimus	Tacrolimus	CAPSULE	ORAL	20230131	N/A	ANDA	ANDA206651	Ajenat Pharmaceuticals LLC	TACROLIMUS	1 mg/1	100 CAPSULE in 1 BOTTLE (82983-401-10)
82983-400-10	82983-400	HUMAN PRESCRIPTION DRUG	Tacrolimus	Tacrolimus	CAPSULE	ORAL	20230131	N/A	ANDA	ANDA206651	Ajenat Pharmaceuticals LLC	TACROLIMUS	.5 mg/1	100 CAPSULE in 1 BOTTLE (82983-400-10)
54288-135-01	54288-135	HUMAN PRESCRIPTION DRUG	Tacrolimus	Tacrolimus	CAPSULE	ORAL	20200408	N/A	ANDA	ANDA206651	BPI LABS LLC	TACROLIMUS	1 mg/1	100 CAPSULE in 1 BOTTLE (54288-135-01)
62250-665-02	62250-665	HUMAN PRESCRIPTION DRUG	Tacrolimus	Tacrolimus	CAPSULE	ORAL	20180425	N/A	ANDA	ANDA206651	Belcher Pharmaceuticals,LLC	TACROLIMUS	.5 mg/1	100 CAPSULE in 1 BOTTLE (62250-665-02)
62250-666-02	62250-666	HUMAN PRESCRIPTION DRUG	Tacrolimus	Tacrolimus Capsules	CAPSULE	ORAL	20180425	N/A	ANDA	ANDA206651	Belcher Pharmaceuticals,LLC	TACROLIMUS	1 mg/1	100 CAPSULE in 1 BOTTLE (62250-666-02)
62250-667-02	62250-667	HUMAN PRESCRIPTION DRUG	Tacrolimus	Tacrolimus Capsules	CAPSULE	ORAL	20180425	N/A	ANDA	ANDA206651	Belcher Pharmaceuticals,LLC	TACROLIMUS	5 mg/1	100 CAPSULE in 1 BOTTLE (62250-667-02)